References
- Thereapeutic Goods Administration. Available at: http://www.tga.gov.au/2
- Department of Health and Aged Care. 2006 Guidelines for Preparation of Submissions to the Pharmaceutical Benefits Advisory Committee (Version 4.1). Commonwealth Government of Australia, Canberra 2006
- Department of Health and Aged Care. The Orphan Drug Program and Improving Community Access to Effective Drugs for Rare Diseases. Commonwealth Government of Australia, Canberra 2001.
- Sudlow C, Carl C. Problems with UK government's risk sharing scheme for assessing drugs for multiple sclerosis. British Medical Journal (Clinical research ed.) 2003; 326: 388–392.
- Chapman S, Reeve E, Rajaratnam G, et al. Setting up an outcomes guarantee for pharmaceuticals: new approach to risk sharing in primary care. British Medical Journal (Clinical research ed.) 2003; 326: 707–709.
- Lu C, Williams K, Day R, et al. Access to high cost drugs in Australia. British Medical Journal (Clinical research ed.) 2004; 329: 415–416.
- Department of Health and Ageing. December 2003 PBAC Outcomes–Positive Recommendations. Pharmaceutical Benefits Scheme, Commonwealth Government of Australia, Canberra 2004
- Keogh A, McNeil K, Williams T, et al. Pulmonary arterial hypertension: a new era in management. Medical Journal of Australia 2003; 178: 564–567.
- Rubin LJ, Badesch BD, Barst RJ, et al. Bosentan treatment for pulmonary arterial hypertension. New England Journal of Medicine 2002; 346: 896–903.
- Keogh AM, McDonald P, WIlliams T, et al. Tracleer (bosentan) for the treatment of pulmonary arterial hypertension: 6 month quality of life data. Journal of Heart and Lung Transplantation 2004;; 23: S54.
- McLaughlin VV, Sitbon O, Badesch BD, et al. Survival with first line bosentan in patients with primary pulmonary hypertension. European Respiratory Journal 2005; 25: 1–6.
- Wlodarczyk J, Cleland LG, Keogh AM, et al. Public funding of bosentan for the treatment of pulmonary artery hypertension in Australia: cost effectiveness and risk sharing. PharmacoEconomics 2006; 24: 903–915
- Carapetis J, Passmore J, O'Grady K. Privacy legislation and research. Medical Journal of Australia 2002;; 177: 523.
- Commonwealth Government of Australia. National Ethics Application Form. Available at: http://www.neaf.gov.au [accessed 10 September 2007].
- National Health Information Management Group. Minimum Guidelines for Health Registers for Statistical and Research Purposes. Australian Institute of Health and Welfare, Canberra 2001
- Gliklich RE, Dreyer NA. (Prepared by the Outcome DEcIDE Center (Outcome Sciences, Inc. dba Outcome), under Contract No. 290-05-0035-1.) AHRQ Publication No. 07-EHC001. Registries for Evaluating Patient Outcomes. Agency for Healthcare Research and Quality, RockvilleMD 2006, (draft released for peer review).
- Williamson OD, Cameron PA, McNeil JJ. Medical registry governance and patient privacy. Medical Journal of Australia 2004; 181: 125–126.